Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling.

Publication ,  Journal Article
Matsumura, N; Mandai, M; Okamoto, T; Yamaguchi, K; Yamamura, S; Oura, T; Baba, T; Hamanishi, J; Kang, HS; Matsui, S; Mori, S; Murphy, SK; Konishi, I
Published in: Cancer Sci
December 2010

The purpose of this study was to investigate a new modality of therapy against ovarian clear cell carcinoma (OCCC), a chemoresistant subtype of ovarian cancer. Microarray datasets of ovarian cancer cell lines and cancer tissues were analyzed using bioinformatic tools. The gene expression profile of OCCC was similar to that of renal cell carcinoma (RCC). This similarity was at least partially due to hepatocyte nuclear factor 1 pathway activation common to both malignancies. In addition, oncogenic pathway alterations were characteristic of OCCC including hypoxia inducible factor 1 alpha subunit and relatively high Ras activities. Therefore, we predicted that the multi-kinase inhibitor sorafenib, which is approved for RCC and suppresses Ras activity, would also be effective against OCCC. Orally administered sorafenib (40 mg/kg per day) significantly inhibited tumor growth in nude mice when it was given after inoculation with the OCCC cell line RMG-2 (P = 0.002). Furthermore, sorafenib significantly reduced tumor size when it was administered to established RMG-2 tumors (P = 0.0002), while intraperitoneal injection of cisplatin (5 mg/kg per week) did not. In conclusion, the prominent anti-tumor effect of sorafenib against OCCC indicates that sorafenib is a promising candidate drug and supports the need for clinical trials using sorafenib against OCCC. This report demonstrates a method to utilize genome-wide information to facilitate translational research for treatments against less common subtypes of cancers.

Duke Scholars

Published In

Cancer Sci

DOI

EISSN

1349-7006

Publication Date

December 2010

Volume

101

Issue

12

Start / End Page

2658 / 2663

Location

England

Related Subject Headings

  • Xenograft Model Antitumor Assays
  • Sorafenib
  • Pyridines
  • Phenylurea Compounds
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Oligonucleotide Array Sequence Analysis
  • Niacinamide
  • Mice, Nude
  • Mice
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Matsumura, N., Mandai, M., Okamoto, T., Yamaguchi, K., Yamamura, S., Oura, T., … Konishi, I. (2010). Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling. Cancer Sci, 101(12), 2658–2663. https://doi.org/10.1111/j.1349-7006.2010.01736.x
Matsumura, Noriomi, Masaki Mandai, Takako Okamoto, Ken Yamaguchi, Shogo Yamamura, Tomonori Oura, Tsukasa Baba, et al. “Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling.Cancer Sci 101, no. 12 (December 2010): 2658–63. https://doi.org/10.1111/j.1349-7006.2010.01736.x.
Matsumura N, Mandai M, Okamoto T, Yamaguchi K, Yamamura S, Oura T, et al. Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling. Cancer Sci. 2010 Dec;101(12):2658–63.
Matsumura, Noriomi, et al. “Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling.Cancer Sci, vol. 101, no. 12, Dec. 2010, pp. 2658–63. Pubmed, doi:10.1111/j.1349-7006.2010.01736.x.
Matsumura N, Mandai M, Okamoto T, Yamaguchi K, Yamamura S, Oura T, Baba T, Hamanishi J, Kang HS, Matsui S, Mori S, Murphy SK, Konishi I. Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling. Cancer Sci. 2010 Dec;101(12):2658–2663.
Journal cover image

Published In

Cancer Sci

DOI

EISSN

1349-7006

Publication Date

December 2010

Volume

101

Issue

12

Start / End Page

2658 / 2663

Location

England

Related Subject Headings

  • Xenograft Model Antitumor Assays
  • Sorafenib
  • Pyridines
  • Phenylurea Compounds
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Oligonucleotide Array Sequence Analysis
  • Niacinamide
  • Mice, Nude
  • Mice